$SRNE KOKI DAR-T system already in phase 1, attractive 3-5 billion buyout if not more due to better CAR-T delivery and efficiency, if they can past phase 2. Also considering that the company owns 25% Celularity which is a 800 million dollar company, and 58% of Scilex ready to IPO anyday now...with a 1.3 billion or more lawsuit handpicked by Hueston Hennigan against PSS catch and kill. Company rejected 3,5 by two separate biopharma and a private equity in January of $7 ...Can we see an offer greater than $9 soon?
  • 8
  • 1